Introduction: Attachment of newly formed crystals to renal epithelial cells is considered to be a critical step in stone formation. Previously, we reported that exogenous fibronectin (FN; 220–240 kDa) had an inhibitory effect against renal tubular cell injury in Madin-Darby canine kidney (MDCK) cells. However, the exact mechanism of FN is not fully understood. To examine the role of FN in crystal-cell interaction, we generated stably transfected MDCK cells that overexpress FN. Materials and Methods: MDCK cells were transfected with rat FN cDNA. First, we assessed cell injury by addition of calcium oxalate monohydrate (COM) crystals. Next, we examined the effect of FN on the adhesion of COM crystals. Finally, we studied the association of COM crystals by scanning electron microscopy. Results: Cell injury was significantly reduced in the transfected cells relative to control MDCK cells. In the inhibitory assay, crystal adhesion decreased markedly as compared with control MDCK cells. Morphological study showed that few crystals were attached to the surface of the transfected cells. Conclusions: We elucidated the relationship between crystal-cell interaction and FN by using FN-overexpressing MDCK cells. We suppose that FN inhibits the adhesion of crystals to cells by coating the renal tubular epithelial cells.

Keywords:
Fibronectin, Nephrolithiasis, Madin-Darby canine kidney cells, Transfection, Madin-Darby canine kidney cells
This content is only available via PDF.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.